Ligand Pharmaceuticals Incorporated Equity-NMS: LGND

$70.37 -0.63 (April 26, 2024)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$71
Open :$70.24
Today's high :$71.17
Today's low :$69.63
52W low :$49.24
52W high :$94.57
1Y :-8.72%
5Y :-13.82%
EPS(TTM): :2.94
Shares O/S :17.71 M
Market cap :1.25 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Ligand Pharmaceuticals Incorporated today?

Ligand Pharmaceuticals Incorporated (LGND) share price as of April 26, 2024, is $70.37. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Ligand Pharmaceuticals Incorporated?

Yes, Indian Investors can invest in the Ligand Pharmaceuticals Incorporated (LGND) Share by opening an international trading account with Angel One.

How can I purchase Ligand Pharmaceuticals Incorporated shares in India?

Purchasing Ligand Pharmaceuticals Incorporated (LGND) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Ligand Pharmaceuticals Incorporated (LGND) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Ligand Pharmaceuticals Incorporated?

Yes, you can purchase fractional shares of Ligand Pharmaceuticals Incorporated (LGND) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Ligand Pharmaceuticals Incorporated?

The market capitalization of Ligand Pharmaceuticals Incorporated on April 26, 2024, is $1.25 B.

In which sector Ligand Pharmaceuticals Incorporated belongs?

Ligand Pharmaceuticals Incorporated operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Ligand Pharmaceuticals Incorporated stocks?

In order to invest in Ligand Pharmaceuticals Incorporated (LGND) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. Its technologies also include HepDirect, LTP and BEPro Technology Platform, SUREtechnology Platform (owned by Selexis), and Pelican Expression Technology. It has established multiple alliances, licenses and other business relationships with various pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International.